Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma-Reference-Cited by-同舟云学术

Nanobubble-mediated co-delivery of Ce6 and miR-195 for synergized sonodynamic and checkpoint blockade combination therapy with elicitation of robust immune response in hepatocellular carcinoma

Published:2022-12 Issue: Volume:181 Page:36-48
ISSN:0939-6411
Container-title:European Journal of Pharmaceutics and Biopharmaceutics
language:en
Short-container-title:European Journal of Pharmaceutics and Biopharmaceutics

Author:

Ma Yao,Li Jinlin,Zhao Yun,Hu Bing,Liu Yun,Liu Chaoqi

Publisher

Elsevier BV

Subject

Pharmaceutical Science,General Medicine,Biotechnology

Reference45 articles.

1. Hepatocellular carcinoma: diagnosis and operative management;Chedid;ABCD, Arq. Bras. Cir. dDg.,2017

2. Regulatory mechanism of MicroRNA expression in cancer;Ali Syeda;Int. J. Mol. Sci.,2020

3. Clinical significance of miR-195 in hepatocellular carcinoma and its biological function in tumor progression;Chen;J. Oncol. Targets Ther.,2019

4. miR-195 inhibits cell proliferation via targeting AEG-1 in hepatocellular carcinoma;Yan;J. Oncol. Lett.,2017

5. Data on the expression of PEPCK in HepG2 hepatocytes transfected with miR-195;Yang;J. Data Brief.,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and Translational Opportunities of Nanocarriers Containing RNAi for the Management of Triple‐Negative Breast Cancer;Advanced Therapeutics;2024-03-25

2. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1/PD-L1 and CTLA-4 pathways;Cancer Cell International;2024-03-10

3. Targeted Ultrasound Nanobubbles Therapy for Prostate Cancer via Immuno-Sonodynamic Effect;International Journal of Nanomedicine;2024-03

4. Liposome-based nanomedicine for immune checkpoint blocking therapy and combinatory cancer therapy;International Journal of Pharmaceutics;2024-03

5. Research progress of nanoparticles in diagnosis and treatment of hepatocellular carcinoma;Open Life Sciences;2024-01-01